Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Cergentis (Utrecht, the Netherlands) provides kits and services based on its proprietary TLA technology. Uniquely, TLA enables targeted complete Next Generation Sequencing of genes and transgenes. TLA provides important unique advantages in the targeted complete sequencing of transgenes, integration sites and of gene editing events. Leading pharmaceutical companies and research institutes use TLA to support the development, selection and quality control of transgenic models, (CHO and CAR-T) cells, and gene editing events.